Alcon Inc.

ALC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $980.0M $1.02B $974.0M $335.0M $376.0M $-531.0M $-656.0M $-227.0M
Depreciation & Amortization — — — — — — — —
Depreciation $417.0M $392.0M $385.0M $330.0M $323.0M $293.0M $267.0M $239.0M
Amortization — — $745.0M $653.0M $590.0M $1.08B $1.08B $1.02B
Stock-Based Compensation $171.0M $162.0M $159.0M $152.0M $151.0M $113.0M $114.0M $93.0M
Net Cash from Operating Activities $2.27B $2.08B $1.39B $1.22B $1.35B $823.0M $920.0M $1.14B
Investing Activities
Capital Expenditures $543.0M $473.0M $658.0M $636.0M $700.0M $479.0M $553.0M $524.0M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-1.34B $-1.17B $-1.09B $-1.87B $-1.20B $-572.0M $-1.01B $-1.00B
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $682.0M — — — — — — —
Net Cash from Financing Activities $-1.12B $-322.0M $-211.0M $-8.0M $-123.0M $466.0M $659.0M $-78.0M
Net Change in Cash $-149.0M $582.0M $114.0M $-595.0M $18.0M $735.0M $595.0M $55.0M
Free Cash Flow $1.73B $1.60B $730.0M $581.0M $645.0M $344.0M $367.0M $616.0M
← Newer Page 1 of 2 Older →